Published in Vaccine Weekly, July 9th, 2003
"In this study, an analysis was made of economic costs and medical effects (by cost-effectiveness and cost-benefit analysis) associated with measles vaccination in a hypothetical Western European country," investigators in Belgium and England report.
"We analyzed 10 vaccination options in terms of past and future vaccination coverage," said Philippe Beutels at the University of Antwerp in Belgium and N. J. Gay at the Public Health Laboratory Service in UK. "We show that several of the proposed strategies for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.